Moreover, GSEA identified enhanced activity of multiple pathways in HHS, among which the PI3K/AKT/mTOR pathway was the most significant, indicating that inhibition of this pathway might be beneficial for the treatment of HS (Figure 2c). The gene discussed is PIK3CB; the disease is hypotrichosis 1.